2016
DOI: 10.1016/j.pharma.2015.07.002
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of new oxadiazole, pyrazole and pyrazolin-5-one bearing 2-((4-methyl-2-oxo-2H-chromen-7-yl)oxy)acetohydrazide analogs as potential antibacterial and antifungal agents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 19 publications
0
2
0
Order By: Relevance
“…Bacteriostatic or bactericide test was determined as follows: a small sample was taken from each well where there was no visible growth, using an inoculation loop, which was then spread on GN plates and incubated overnight at 37°C [36]. The minimum inhibitory concentration (MIC) was the lowest concentration of test compound that inhibit the visible growth of the organism and was determined in triplicates [37]. Table 3.…”
Section: Antibacterial and Anti Fungal Activitymentioning
confidence: 99%
“…Bacteriostatic or bactericide test was determined as follows: a small sample was taken from each well where there was no visible growth, using an inoculation loop, which was then spread on GN plates and incubated overnight at 37°C [36]. The minimum inhibitory concentration (MIC) was the lowest concentration of test compound that inhibit the visible growth of the organism and was determined in triplicates [37]. Table 3.…”
Section: Antibacterial and Anti Fungal Activitymentioning
confidence: 99%
“…Pyrazolin‐5‐ones, representing an important class of five‐membered‐ring lactams, are common privileged scaffolds in medicinal chemistry and appear in many pharmaceutical agents. For example, Ramana and the co‐workers reported the novel pyrazolin‐5‐one derivatives with very good antibacterial activities; Premnath et al. synthesized the pyrazolin‐5‐one‐based leader with the cytotoxic activity against SiHa cell line; the novel pyrazolin‐5‐one‐based fatty acid elong'ase 6 (ELOVL6) inhibitors were developed by Sato et al.…”
Section: Introductionmentioning
confidence: 99%